171 related articles for article (PubMed ID: 23083343)
21. Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines.
Mobasheri MB; Shirkoohi R; Zendehdel K; Jahanzad I; Talebi S; Afsharpad M; Modarressi MH
Tumour Biol; 2015 Sep; 36(10):8201-6. PubMed ID: 25994570
[TBL] [Abstract][Full Text] [Related]
22. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
[TBL] [Abstract][Full Text] [Related]
23. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
Front Immunol; 2018; 9():947. PubMed ID: 29770138
[TBL] [Abstract][Full Text] [Related]
24. Mutant p53 in breast cancer: potential as a therapeutic target and biomarker.
Duffy MJ; Synnott NC; Crown J
Breast Cancer Res Treat; 2018 Jul; 170(2):213-219. PubMed ID: 29564741
[TBL] [Abstract][Full Text] [Related]
25. The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion.
Maine EA; Westcott JM; Prechtl AM; Dang TT; Whitehurst AW; Pearson GW
Oncotarget; 2016 Mar; 7(12):14708-26. PubMed ID: 26895102
[TBL] [Abstract][Full Text] [Related]
26. Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application.
Wei R; Dean DC; Thanindratarn P; Hornicek FJ; Guo W; Duan Z
Cancer Lett; 2020 Jun; 479():54-60. PubMed ID: 31634526
[TBL] [Abstract][Full Text] [Related]
27. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer.
Nin DS; Deng LW
Cells; 2023 Mar; 12(6):. PubMed ID: 36980267
[TBL] [Abstract][Full Text] [Related]
28. Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas.
Olsen L; Campos B; Winther O; Sgroi DC; Karger BL; Brusic V
BMC Med Genomics; 2014; 7 Suppl 3(Suppl 3):S2. PubMed ID: 25521819
[TBL] [Abstract][Full Text] [Related]
29. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
[TBL] [Abstract][Full Text] [Related]
30. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.
Bodey B
Expert Opin Biol Ther; 2002 Aug; 2(6):577-84. PubMed ID: 12171503
[TBL] [Abstract][Full Text] [Related]
31. A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence.
Zamunér FT; Karia BT; de Oliveira CZ; Santos CR; Carvalho AL; Vettore AL
Mol Cancer Ther; 2015 Mar; 14(3):828-34. PubMed ID: 25564441
[TBL] [Abstract][Full Text] [Related]
32. Inducible expression of cancer-testis antigens in human prostate cancer.
Heninger E; Krueger TE; Thiede SM; Sperger JM; Byers BL; Kircher MR; Kosoff D; Yang B; Jarrard DF; McNeel DG; Lang JM
Oncotarget; 2016 Dec; 7(51):84359-84374. PubMed ID: 27769045
[TBL] [Abstract][Full Text] [Related]
33. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.
Sansone P; Storci G; Tavolari S; Guarnieri T; Giovannini C; Taffurelli M; Ceccarelli C; Santini D; Paterini P; Marcu KB; Chieco P; Bonafè M
J Clin Invest; 2007 Dec; 117(12):3988-4002. PubMed ID: 18060036
[TBL] [Abstract][Full Text] [Related]
34. Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis.
Chander H; Brien CD; Truesdell P; Watt K; Meens J; Schick C; Germain D; Craig AW
Breast Cancer Res; 2014 Dec; 16(6):3413. PubMed ID: 25547174
[TBL] [Abstract][Full Text] [Related]
35. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer.
Dimas-González J; Maldonado-Lagunas V; Díaz-Chávez J; López-Arellano ME; Muñoz-Camacho J; Terán-Porcayo MA; Lagunas-Martínez A
Oncol Rep; 2017 May; 37(5):3026-3036. PubMed ID: 28393224
[TBL] [Abstract][Full Text] [Related]
37. Molecular markers for breast cancer: prediction on tumor behavior.
Banin Hirata BK; Oda JM; Losi Guembarovski R; Ariza CB; de Oliveira CE; Watanabe MA
Dis Markers; 2014; 2014():513158. PubMed ID: 24591761
[TBL] [Abstract][Full Text] [Related]
38. [THE ROLE OF TUMORAL STROMA IN PREDICTING OF THE SEVERITY COURSE IN PATIENTS, SUFFERING MAMMARY GLAND CANCER WITH P53 HYPEREXPRESSION].
Shchurov NF
Klin Khir; 2015 May; (5):61-4. PubMed ID: 26419039
[TBL] [Abstract][Full Text] [Related]
39. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.
Schwartz T; Stark A; Pang J; Awuah B; Kleer CG; Quayson S; Kingman S; Aitpillah F; Abantanga F; Jiagge E; Oppong JK; Osei-Bonsu E; Martin I; Yan X; Toy K; Adjei E; Wicha M; Newman LA
Cancer; 2013 Feb; 119(3):488-94. PubMed ID: 22930220
[TBL] [Abstract][Full Text] [Related]
40. The GALNT6‑LGALS3BP axis promotes breast cancer cell growth.
Kimura R; Yoshimaru T; Matsushita Y; Matsuo T; Ono M; Park JH; Sasa M; Miyoshi Y; Nakamura Y; Katagiri T
Int J Oncol; 2020 Feb; 56(2):581-595. PubMed ID: 31894262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
